DuPont Conducts Research at its Semiconductor Materials Technical Center in Taiwan

In an effort to develop new semiconductor packaging technologies, DuPont Wafer Level Packaging Solutions, part of DuPont Electronic Technologies, has signed a joint-development agreement with Nippon Kayaku Co. Ltd. (NKC) and its wholly owned subsidiary, MicroChem Corp. Wafer level packaging refers to the technology of packaging an integrated circuit at wafer level, instead of the traditional process of assembling the package of each individual unit after wafer dicing.

The electronic materials developed under the agreement will be new advanced photodefinable epoxy-based materials. They will be directed at wafer level packaging, 3D and through-silicon via (TSV) semiconductor packaging applications that are transforming electronics to make them smaller, lighter weight, more functional and more cost-effective.

“Combining the expertise of Nippon Kayaku and MicroChem in advanced epoxy resins and formulation, with DuPont coating technology, material science and electronic applications knowledge means that we can generate a series of enabling materials faster,” said Mats Ehlin, global business manager, DuPont Wafer Level Packaging Solutions. “We’re excited about this opportunity to further expand our offering and strengthen our ability to help customers meet their needs for improved performance, form factor and reduced cost.”

DuPont estimates the materials market for wafer level packaging, 3D and TSV will grow from about USD 100 million in 2009, to more than USD 600 million in 2013, and could as much as double to USD 1.2 billion by 2015. Wafer level packaging is spreading rapidly as a way to significantly improve the efficiency and reduce the size of semiconductor packages.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.